 Clinical course anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis systemic vasculitis Glomerular Disease Collaborative Network OBJECTIVES spectrum clinical manifestations patients anti-neutrophil cytoplasmic autoantibody ANCA glomerulonephritis renal patient survival patients survival patients corticosteroids corticosteroids intravenous cyclophosphamide corticosteroids oral cyclophosphamide correlation disease manifestations treatment response ANCA subtypes serial autoantibody titers DESIGN Inception cohort study mean follow-up months SETTING Collaborative network university private practice nephrologists Glomerular Disease Collaborative Network PARTICIPANTS Seventy patients ANCA pauci-immune necrotizing crescentic glomerulonephritis corticosteroids patients corticosteroids oral cyclophosphamide patients corticosteroids intravenous cyclophosphamide patients MAIN RESULTS patients disease idiopathic crescentic glomerulonephritis nonpulmonary extrarenal disease consistent polyarteritis nodosa pulmonary disease consistent Wegener granulomatosis alveolar capillaritis manifestations disease patients autoantibodies cytoplasmic pattern patients autoantibodies perinuclear pattern perinuclear pattern patients renal-limited disease Renal patient survival months difference survival patients renal-limited disease systemic disease differences survival patients oral cyclophosphamide intravenous cyclophosphamide comparative data patients corticosteroids inconclusive general autoantibody titers response treatment disease activity exceptions CONCLUSIONS Patients ANCA various forms vascular inflammation renal-limited disease widespread systemic vasculitis polyarteritis nodosa Wegener granulomatosis Oral corticosteroids oral intravenous cyclophosphamide effective therapy ANCA-associated glomerulonephritis